The third-generation GENOSYL delivery system (DS) is a tankless and portable system that delivers a constant concentration of inhaled nitric oxide gas with rapid dosing, simplified workflow, and enhanced operational efficiency
GENOSYL DS Console. (Credit: PRNewswire/VERO Biotech Inc.)
US-based medical equipment supplier VERO Biotech has received the US Food and Drug Administration approval for its new-generation tankless inhaled nitric oxide (iNO) delivery system.
The third-generation GENOSYL delivery system (DS) is designed with features that enable rapid dosing, simplified workflow, and enhanced operational efficiency.
The device comes with an adaptive sensor and automated cassette activation that enables rapid dosing by advancing the time to achieve the desired dose.
It features a dual cassette bay within each console, to simplify the clinicians’ workflow. It enables them to work from a single console, and transitions cassettes automatically.
In addition, the device is said to improve the user interface with smaller, lighter disposable cassettes that mitigate storage constraints, to enable operational efficiency.
VERO Biotech CEO and president Brent V Furse said: “The continuous innovation of the GENOSYL Delivery System represents our commitment to neonatal intensive care and the acute care hospital community in providing solutions to the challenges they face.
“We are grateful for the partnership and support we received with the launch of our innovative tankless GENOSYL Delivery System and this collaboration that has and will allow VERO Biotech to continue to expand on its mission to save lives, alleviate suffering and improve the health economics of acute care.”
GENOSYL (nitric oxide gas for inhalation) is indicated for neonates with hypoxic respiratory failure related to pulmonary hypertension, along with ventilatory support and other agents.
Inhaled Nitric Oxide is said to dilate pulmonary blood vessels and is used to improve oxygenation in neonates with hypoxic respiratory failure and pulmonary hypertension.
VERO Biotech said that GENOSYL DS is a tankless and portable system engineered to deliver a constant concentration of inhaled nitric oxide gas to patients.
Unlike tank-based systems, it generates iNO using a small disposable cassette, and is the first tankless inhaled nitric oxide delivery system approved in the US, said the company.